TOPOTARGET | 0,364 Euro | +0,003 +0,83 % | |
| WKN: A0ERXB ISIN: DK0060003556 Ticker-Symbol: T5I | Frankfurt | 25.05.12 | 17:00 Uhr |
Branche PharmaAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 25.05. | Topotarget: Time and date for telephone conference related to the publishing of the interim report for Q1 2012 | 25 | GlobeNewswire | |
| To NASDAQ OMX Copenhagen A/S
Investor News No. 03-12 / Copenhagen, May 25, 2012
Copenhagen, Denmark - May 25, 2012 - Today Topotarget A/S (NASDAQ OMX: TOPO)
announced that a telephone conference will... Mehr lesen zu: Topotarget: Time and date for telephone conference related to the publishing of the interim report for Q1 2012 | ||||
| 17.05. | Topotarget: Clinical data on belinostat for ASCO 2012 | 64 | GlobeNewswire | |
| To NASDAQ OMX Copenhagen A/S
Announcement No. 08-12 / Copenhagen, May 17, 2012
Copenhagen, Denmark - May 17, 2012 - Today Topotarget A/S (NASDAQ OMX: TOPO)
announced that abstracts on belinostat clinical... Mehr lesen zu: Topotarget: Clinical data on belinostat for ASCO 2012 | ||||
| 02.05. | Topotarget: Topotarget issues warrants to Employees, Management and Board of Directors | 17 | GlobeNewswire | |
| To NASDAQ OMX Copenhagen A/S
Announcement No. 07-12 / Copenhagen, 2 May, 2012
Copenhagen, Denmark - 2 May, 2012 - Topotarget A/S (NASDAQ OMX: TOPO) has
announced that 1,025,000 warrants have been... Mehr lesen zu: Topotarget: Topotarget issues warrants to Employees, Management and Board of Directors | ||||
| 11.04. | Topotarget: Passing on Topotarget A/S Annual General Meeting | 27 | GlobeNewswire | |
| To NASDAQ OMX Copenhagen A/S
Announcement No. 06-12 / Copenhagen, April 11, 2012
Copenhagen, Denmark - April 11, 2012 - Topotarget A/S (NASDAQ OMX: TOPO) held
its Annual General Meeting today at Symbion... Mehr lesen zu: Topotarget: Passing on Topotarget A/S Annual General Meeting | ||||
| 19.03. | Topotarget: Notice to Convene Annual General Meeting | 27 | GlobeNewswire | |
| To NASDAQ OMX Copenhagen A/S
Announcement No. 05-12 / Copenhagen, March 19, 2012
Notice is hereby given that the Annual General Meeting of Topotarget A/S will
be held on:
Wednesday April 11, 2012... Mehr lesen zu: Topotarget: Notice to Convene Annual General Meeting | ||||
| 14.03. | Topotarget: CORRECTION: Topotarget announces financial results for the year ended December 31, 2011 | 40 | GlobeNewswire | |
| To NASDAQ OMX Copenhagen A/S
Announcement No. 04-12 / Copenhagen, March 14, 2012
Copenhagen, Denmark - March 14, 2012 - Today Topotarget A/S (NASDAQ OMX: TOPO)
announced the financial results for... Mehr lesen zu: Topotarget: CORRECTION: Topotarget announces financial results for the year ended December 31, 2011 | ||||
| 14.03. | Topotarget: Topotarget announces financial results for the year ended December 31, 2011 | 51 | GlobeNewswire | |
| To NASDAQ OMX Copenhagen A/S
Announcement No. 04-12 / Copenhagen, March 14, 2012
Copenhagen, Denmark - March 14, 2012 - Today Topotarget A/S (NASDAQ OMX: TOPO)
announced the financial results for... Mehr lesen zu: Topotarget: Topotarget announces financial results for the year ended December 31, 2011 | ||||
| 09.03. | Topotarget: Topotarget announces the time and date for the telephone conference related to the publishing of the annual report 2011 | 34 | GlobeNewswire | |
| To NASDAQ OMX Copenhagen A/S
Investor News No. 02-12 / Copenhagen, March 9, 2012
Copenhagen, Denmark - March 9, 2012 - Topotarget A/S (NASDAQ OMX: TOPO)
announces that a teleconference will be held... Mehr lesen zu: Topotarget: Topotarget announces the time and date for the telephone conference related to the publishing of the annual report 2011 | ||||
| 29.02. | Topotarget: Abstract for the American Association for Cancer Research 2012 | 89 | GlobeNewswire | |
| Copenhagen, Denmark - February 29, 2012 - Today Topotarget A/S (NASDAQ OMX:
TOPO) announced that clinical data on belinostat will be presented at the 2012
American Association for Cancer Research... Mehr lesen zu: Topotarget: Abstract for the American Association for Cancer Research 2012 | ||||
| 24.02. | NASDAQ OMX Copenhagen A/S: Reprimand to Topotarget | 27 | GlobeNewswire | |
| Copenhagen, 24 February 2012
Disclosure of price sensitive information in a press release
NASDAQ OMX Copenhagen has given a reprimand to Topotarget A/S as the
information in the company's press release... Mehr lesen zu: NASDAQ OMX Copenhagen A/S: Reprimand to Topotarget | ||||
| 18.01. | Topotarget: Abstract for ASCO Gastrointestinal Cancers Symposium 2012 | 50 | GlobeNewswire | |
| Copenhagen, 2012-01-18 11:01 CET (GLOBE NEWSWIRE) --
Copenhagen, Denmark - January 18, 2012 - Today Topotarget A/S (NASDAQ OMX:
TOPO.CO) announced that clinical data on belinostat will be presented... Mehr lesen zu: Topotarget: Abstract for ASCO Gastrointestinal Cancers Symposium 2012 | ||||
| 05.01. | Topotarget: Topotarget A/S formalizes previous announcements regarding the divestiture of Totect® | 29 | GlobeNewswire | |
| Copenhagen, Denmark - January 5, 2012 - Topotarget A/S (NASDAQ-OMX: TOPO.CO)
incorrectly announced the company's two recent announcements related to the
divestment of Totect® to Apricus Biosciences... Mehr lesen zu: Topotarget: Topotarget A/S formalizes previous announcements regarding the divestiture of Totect® | ||||
| 29.12. | Apricus Biosciences Closes Acquisition Of Topotarget USA | 88 | AFX News | |
| WASHINGTON (dpa-AFX) - Apricus Biosciences Inc.(APRI) announced the closing
of its acquisition of Topotarget USA Inc., a subsidiary of Topotarget A/S, a
Danish company listed on the Copenhagen... Mehr lesen zu: Apricus Biosciences Closes Acquisition Of Topotarget USA | ||||
| 29.12. | Apricus (APRI) Closes Topotarget Acquisition, Will Change Name to 'Apricus Pharmaceuticals USA' | 3 | StreetInsider.com | |
| 29.12. | Apricus Biosciences, Inc.: Apricus Biosciences Completes Acquisition of Topotarget USA, Inc. | 76 | GlobeNewswire | |
| To Rename the Newly Acquired Company, Apricus Pharmaceuticals USA, Inc.
SAN DIEGO, Dec. 29, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc.
("Apricus Bio") (Nasdaq:APRI) (http://www.apricusbio.com)... Mehr lesen zu: Apricus Biosciences, Inc.: Apricus Biosciences Completes Acquisition of Topotarget USA, Inc. | ||||
| 29.12. | Topotarget: Topotarget A/S announces the successful completion of the divestiture of Totect® and Topotarget USA, Inc to Apricus Biosciences, Inc. | 64 | GlobeNewswire | |
| Copenhagen, Denmark - December 30, 2011 - Topotarget A/S (NASDAQ-OMX: TOPO.CO)
has today announced the completion of Apricus Biosciences, Inc.'s purchase of
100% of the outstanding common stock of... Mehr lesen zu: Topotarget: Topotarget A/S announces the successful completion of the divestiture of Totect® and Topotarget USA, Inc to Apricus Biosciences, Inc. | ||||
| 29.12. | Apricus Biosciences Completes Acquisition of Topotarget USA, Inc. | 120 | dpa-AFX | |
| Apricus Biosciences Completes Acquisition of Topotarget USA,
Inc.
Apricus Biosciences, Inc.
29.12.2011 18:30
--------------------------------------------------------------------
-------
To... Mehr lesen zu: Apricus Biosciences Completes Acquisition of Topotarget USA, Inc. | ||||
| 16.12. | Apricus Biosciences To Buy Topotarget USA | 63 | AFX News | |
| WASHINGTON (dpa-AFX) - Apricus Biosciences, Inc. (APRI) said Friday that it
has agreed to buy Topotarget USA, Inc., a subsidiary of Topotarget A/S. Topotarget USA owns Totect, the only drug... Mehr lesen zu: Apricus Biosciences To Buy Topotarget USA | ||||
| 16.12. | Apricus Biosciences, Inc.: Apricus Biosciences Launches Commercialization Arm With Definitive Agreement to Acquire Topotarget USA | 14 | GlobeNewswire | |
| First Acquisition by Apricus Bio of an FDA Approved and Marketed US Drug
SAN DIEGO, 2011-12-16 14:00 CET (GLOBE NEWSWIRE) --
Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI)
announced... Mehr lesen zu: Apricus Biosciences, Inc.: Apricus Biosciences Launches Commercialization Arm With Definitive Agreement to Acquire Topotarget USA | ||||
| 16.12. | Topotarget: Topotarget A/S announces the divestiture of Totect® to Apricus Biosciences, Inc., and improved financial expectations for 2011 | 28 | GlobeNewswire | |
| Copenhagen, Denmark - December 16, 2011 - Topotarget A/S (NASDAQ-OMX: TOPO.CO)
has announced today that Apricus Biosciences, Inc. has entered into an
agreement to purchase 100% of the outstanding... Mehr lesen zu: Topotarget: Topotarget A/S announces the divestiture of Totect® to Apricus Biosciences, Inc., and improved financial expectations for 2011 | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| ACADIA PHARMACEUTICALS INC | 1,071 | -5,22 % | Hot Stock: Acadia Pharmaceuticals, Shares Drop 6.0% |
| STADA ARZNEIMITTEL AG | 24,840 | -0,64 % | Kepler hebt Ziel für Stada auf 32 Euro - 'Buy' |
| GILEAD SCIENCES INC | 40,071 | -0,24 % | Erfolg für GILEAD |
| INCYTE CORPORATION | 18,004 | +0,60 % | Incyte to Present at Upcoming Investor Conferences |
| ASTRAZENECA PLC | 32,760 | -0,40 % | Kepler startet AstraZeneca mit 'Hold' - Ziel 2.700 Pence |
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
